D. D. Des Jarlais

发表

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Mohammad Hossein Khosravi, Eun Sug Park, Aditya Prasad Dash, 2018, Lancet.

Alternatives to the randomized controlled trial.

David R. Holtgrave, M. Fishbein, N. Duan, 2008, American journal of public health.

HIV Among Drug Users at Beth Israel Medical Center, New York City, the First 25 Years

D. D. Des Jarlais, S. Friedman, K. Arasteh, 2011, Substance use & misuse.

Barriers and Facilitators to Undergoing Hepatitis C Virus (HCV) Testing through Drug Treatment Programs

D. D. Des Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2008 .

Receptive Syringe Sharing Among Injection Drug Users in Harlem and the Bronx During the New York State Expanded Syringe Access Demonstration Program

D. Vlahov, D. D. Des Jarlais, S. Blaney, 2005, Journal of acquired immune deficiency syndromes.

Long-term effects of syringe exchange on risk behavior and HIV prevention.

D. D. Des Jarlais, D. Purchase, Naomi Braine, 2004, AIDS education and prevention : official publication of the International Society for AIDS Education.

Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.

Don C Des Jarlais, Nicole Crepaz, N. Crepaz, 2004, American journal of public health.

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

Eyal Oren, Mark Strong, Ronan A Lyons, 2017, The Lancet.

History, ethics, and politics in AIDS prevention research.

D. D. Des Jarlais, B. Stepherson, 1991, American journal of public health.

Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?

D. D. Des Jarlais, H. Hagan, S. Tross, 2015, PloS one.

Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.

D. D. Des Jarlais, J. Molès, N. Nagot, 2017, Drug and alcohol dependence.

Racial/Ethnic Disparities at the End of an HIV Epidemic: Persons Who Inject Drugs in New York City, 2011-2015

D. D. Des Jarlais, S. Tross, S. Friedman, 2017, American journal of public health.

Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs.

Don C Des Jarlais, Samuel R Friedman, D. D. Des Jarlais, 2004, Addiction.

Tuberculosis in drug users.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The study of transitions in the route of drug use: the route from one route to another.

D. D. Des Jarlais, J. Strang, M. Gossop, 1992, British journal of addiction.

Syphilis in drug users in low and middle income countries.

D. D. Des Jarlais, H. Hagan, D. Perlman, 2010, The International journal on drug policy.

HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women.

R. Garfein, D. D. Des Jarlais, S. Friedman, 2003, American journal of public health.

Injection and Heterosexual Risk Behaviors for HIV Infection Among Non-gay Identifying Men Who Have Sex with Men and Women

D. D. Des Jarlais, K. Arasteh, J. Feelemyer, 2019, AIDS and Behavior.

Risk factors and HIV seropositivity among injecting drug users in Bangkok.

D. D. Des Jarlais, S. Friedman, M. Carballo, 1991, AIDS.

Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

D. D. Des Jarlais, D. Perlman, J. Feelemyer, 2015, Journal of addictive diseases.

Viral Hepatitis Among Drug Users in Methadone Maintenance: Associated Factors, Vaccination Outcomes, and Interventions

D. D. Des Jarlais, K. Delucchi, J. Sorensen, 2014, Journal of addictive diseases.

The methamphetamine epidemic among persons who inject heroin in Hai Phong, Vietnam.

D. D. Des Jarlais, J. Molès, K. Arasteh, 2021, Journal of substance abuse treatment.

Effectiveness of Respondent-Driven Sampling for Recruiting Drug Users in New York City: Findings from a Pilot Study

Douglas D. Heckathorn, Courtney McKnight, Kathleen Gallagher, 2006, Journal of Urban Health.

“Informed Altruism” and “Partner Restriction” in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990–2001

D. D. Des Jarlais, H. Hagan, S. Friedman, 2004, Journal of acquired immune deficiency syndromes.

Prevalence of hepatitis A among drug users in north-eastern Italy. Is vaccination necessary in low prevalence areas?

D. D. Des Jarlais, G. Talamini, G. Quaglio, 2005, European journal of public health.

Quality of care in patients with chronic hepatitis C virus infection.

D. D. Des Jarlais, D. Perlman, A. Talal, 2011, Annals of internal medicine.

Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion

D. D. Des Jarlais, H. Hagan, H. Thiede, 2004, Epidemiology.

Research, politics, and needle exchange.

D. D. Des Jarlais, 2000, American journal of public health.

HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis

D. D. Des Jarlais, A. Uusküla, E. Läärä, 2015, BMJ Open.

Feasibility of a simple and scalable cognitive-behavioral intervention to treat problem substance use

D. D. Des Jarlais, D. M. Barnes, David M. Barnes, 2019, Journal of substance use.

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.

D. D. Des Jarlais, H. Hagan, P. Flom, 2007, The International journal on drug policy.

The psychology of preventing AIDS among intravenous drug users. A social learning conceptualization.

D. D. Des Jarlais, S. Friedman, 1988, The American psychologist.

High HIV Seroprevalence Epidemics among Injecting Drug Users; New York City and Bangkok

D. D. Des Jarlais, S. Friedman, P. Friedmann, 1997 .

HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.

D. D. Des Jarlais, P. Carrieri, T. Kerr, 2016, AIDS.

Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.

A. Abdul-Quader, D. D. Des Jarlais, H. Hagan, 2014, Addiction.

At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City.

D. D. Des Jarlais, K. Arasteh, 2009, AIDS patient care and STDs.

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

D. D. Des Jarlais, B. Edlin, M. Glesby, 2017, PloS one.

Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

D. D. Des Jarlais, D. Perlman, A. Talal, 2013, Journal of substance abuse treatment.

The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.

D. Vlahov, R. Garfein, D. Holtzman, 2009, Preventive medicine.

Hepatitis C virus‐specific T‐cell immune responses in seronegative injection drug users

D. D. Des Jarlais, M. Busch, B. Edlin, 2009, Journal of viral hepatitis.

Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.

D. D. Des Jarlais, Naomi Braine, C. Turner, 2007, AIDS education and prevention : official publication of the International Society for AIDS Education.

Drug treatment programs' HCV service delivery to their HCV positive clients

D. D. Des Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2006 .

Staff Perspectives on Facilitating the Implementation of Hepatitis C Services at Drug Treatment Programs

D. D. Des Jarlais, H. Hagan, S. Strauss, 2006, Journal of psychoactive drugs.

Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.

D. D. Des Jarlais, H. Hagan, S. Strauss, 2005, AIDS patient care and STDs.

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001

D. D. Des Jarlais, L. Torian, H. Hagan, 2005, AIDS.

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

D. D. Des Jarlais, H. Hagan, H. Thiede, 2005, AIDS.

Hepatitis C Service Delivery in Prisons: Peer Education From the “Guys in Blue”

D. D. Des Jarlais, H. Hagan, S. Strauss, 2005 .

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

D. D. Des Jarlais, H. Hagan, Z. Vassilev, 2003, Journal of substance abuse treatment.

A nationwide survey of hepatitis C services provided by drug treatment programs.

D. D. Des Jarlais, Z. Vassilev, S. Strauss, 2002, Journal of substance abuse treatment.

Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users?

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2002, Epidemiology.

Heroin activity in New York City, 1970-1978.

D. D. Des Jarlais, D. C. Jarlais, G. Uppal, 1980, The American journal of drug and alcohol abuse.

Syringe exchange, injecting and intranasal drug use.

D. D. Des Jarlais, S. Friedman, K. Arasteh, 2010, Addiction.

More rare birds, and the occasional swan.

D. D. Des Jarlais, T. O'Brien, M. Busch, 2009, Gastroenterology.

Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy.

D. Vlahov, D. D. Des Jarlais, P. Lurie, 2001, American journal of epidemiology.

Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2009, The International journal on drug policy.

Recurrent Injecting Drug Use as a Mediator between Psychiatric Disorder and Non-Fatal Overdose

D. D. Des Jarlais, D. M. Barnes, Shu Xu, 2022, Substance use & misuse.

Mortality Risk Among Recent-Onset Injection Drug Users in Five U.S. Cities

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2008, Substance use & misuse.

Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

D. D. Des Jarlais, H. Hagan, E. Pouget, 2012, Addiction.

Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis

D. D. Des Jarlais, H. Hagan, D. Perlman, 2017, International journal of STD & AIDS.

Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.

D. D. Des Jarlais, H. Hagan, Ashly E. Jordan, 2017, Journal of substance abuse treatment.

Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs

D. D. Des Jarlais, J. Molès, N. Nagot, 2022, Frontiers in Psychiatry.

Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.

D. D. Des Jarlais, N. Salomon, D. Perlman, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.

D. D. Des Jarlais, D. Nash, K. Arasteh, 2015, Drug and alcohol dependence.

Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

D. D. Des Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2007, BMC Health Services Research.

Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy

D. D. Des Jarlais, G. Talamini, G. Quaglio, 2003, Journal of viral hepatitis.

30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs

D. D. Des Jarlais, H. Hagan, S. Pinkerton, 2013, Advances in preventive medicine.

Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

D. Holtzman, D. D. Des Jarlais, J. Feelemyer, 2015, MMWR. Morbidity and mortality weekly report.

Research Note: Perspectives on the Hierarchy of HIV and Hepatitis C Disease: Consequences for Drug Treatment Program Patients

D. D. Des Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2010 .

HCV (Hepatitis C Virus) Pre-Test and Post-Test Counseling Services at Drug Treatment Programs: Missed Opportunities for Primary Prevention

D. D. Des Jarlais, H. Hagan, S. Strauss, 2005 .

Provision of Hepatitis C Education in a Nationwide Sample of Drug Treatment Programs

D. D. Des Jarlais, Z. Vassilev, S. Strauss, 2003, Journal of drug education.

Alcohol and HIV sexual risk behaviors among injection drug users.

D. D. Des Jarlais, K. Arasteh, T. Perlis, 2008, Drug and alcohol dependence.

Deren et al. Respond.

D. D. Des Jarlais, S. Deren, C. Gelpí-Acosta, 2015, American journal of public health.

Alternative kinship structures, resilience and social support among immigrant trans Latinas in the USA

D. D. Des Jarlais, S. Hwahng, C. McKnight, 2019, Culture, health & sexuality.

Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study

David M. Pereira, R. Malekzadeh, T. Vos, 2017, International Journal of Public Health.

Re: "quality of reporting of observational longitudinal research".

N. Crepaz, D. D. Des Jarlais, C. Lyles, 2005, American journal of epidemiology.

Anti-Vaccine Attitudes among Adults in the U.S. during the COVID-19 Pandemic after Vaccine Rollout

D. D. Des Jarlais, V. Chang, Lawrence H. Yang, 2022, Vaccines.

Is your syringe services program cost-saving to society? A methodological case study

D. D. Des Jarlais, J. Feelemyer, S. Glick, 2021, Harm Reduction Journal.

Target groups for preventing AIDS among intravenous drug users: 2. The "hard" data studies.

D. D. Des Jarlais, S. Friedman, C. Casriel, 1990, Journal of consulting and clinical psychology.

Strategies for universalistic and targeted HIV prevention.

D. D. Des Jarlais, N. Padian, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

High compliance with a hepatitis B virus vaccination program among intravenous drug users.

D. D. Des Jarlais, F. Lugoboni, P. Mezzelani, 1991, The Journal of infectious diseases.

Knowledge of hepatitis among active drug injectors at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, P. Friedmann, 2005, Journal of substance abuse treatment.

Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users.

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2001, Journal of substance abuse.

Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia

Michael A. Joseph, D. D. Des Jarlais, A. Uusküla, 2018, International journal of STD & AIDS.

Organizational issues in conducting tuberculosis screening at a syringe exchange program.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1998, Journal of substance abuse treatment.

"Shotgunning" as an illicit drug smoking practice.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1997, Journal of substance abuse treatment.

Crack cocaine use in a cohort of methadone maintenance patients.

D. D. Des Jarlais, M. Marmor, J. Wenston, 1992, Journal of substance abuse treatment.

Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001-2005 and 2011-2015.

D. D. Des Jarlais, S. Tross, K. Arasteh, 2018, Drug and alcohol dependence.

Mortgage Discrimination and Racial/Ethnic Concentration Are Associated with Same-Race/Ethnicity Partnering among People Who Inject Drugs in 19 US Cities

D. D. Des Jarlais, S. Friedman, Z. Ross, 2020, Journal of Urban Health.

Locus of control and initiation of detoxification among male methadone maintenance patients.

D. D. Des Jarlais, J. Langrod, J. Lowinson, 1983, The International journal of the addictions.

State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness

D. D. Des Jarlais, K. Arasteh, J. Feelemyer, 2015, Journal of public health policy.

Responding to a surge in overdose deaths: perspectives from US syringe services programs

D. D. Des Jarlais, B. Schackman, E. Williams, 2022, Harm Reduction Journal.

HIV epidemiology and interventions among injecting drug users

D. D. Des Jarlais, S. Friedman, 1996, International journal of STD & AIDS.

An Overview of AIDS Prevention Efforts Aimed at Intravenous Drug Users Circa 1987

D. D. Des Jarlais, S. Friedman, D. Goldsmith, 1989 .

Predictors and risk-taking consequences of drug use among HIV-infected women.

D. D. Des Jarlais, J. Dehovitz, H. Minkoff, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.

D. D. Des Jarlais, H. Wolfe, T. Mastro, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Small world, big challenges: a report from the 9th International Congress of the World Federation of Public Health Associations.

D. D. Des Jarlais, D. C. Jarlais, A. Jones, 2001, American journal of public health.

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review

A. Abdul-Quader, D. D. Des Jarlais, H. Hagan, 2013, BMC Public Health.

Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach.

D. D. Des Jarlais, S. Deren, C. Gelpí-Acosta, 2014, American journal of public health.

T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2016, Viral immunology.

Current and Emerging Research Needs in Studying the NYC HIV–Drug Use Epidemic

D. D. Des Jarlais, H. Hagan, S. Friedman, 2011, Substance use & misuse.

Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review

D. D. Des Jarlais, J. Ward, W. Hall, 1994 .

A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death.

D. D. Des Jarlais, S. Friedman, G. Quaglio, 1998, AIDS care.

Self-concept and drug involvement among urban junior high school youths.

D. D. Des Jarlais, R. Dembo, J. Schmeidler, 1979, The International journal of the addictions.

HIV risk behaviors among female IDUs in developing and transitional countries

D. D. Des Jarlais, G. Stimson, C. Cleland, 2007, BMC public health.

Knowing quitters predicts smoking cessation in a homeless population.

D. D. Des Jarlais, A. Joseph, L. Gelberg, 2013, American journal of health behavior.

Methadone dosage, program policies, and heroin use among methadone patients.

D. D. Des Jarlais, R. Newman, 1992, Journal of substance abuse treatment.

Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study

Josephine G. Walker, D. D. Des Jarlais, P. Vickerman, 2020, PloS one.

HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic

D. D. Des Jarlais, M. Raag, A. Uusküla, 2017, PloS one.

Place-Based Correlates of Exchange Sex Among People Who Inject Drugs in 19 U.S. Metropolitan Areas, 2012

Howard H. Chang, D. D. Des Jarlais, Justin C. Smith, 2021, Archives of Sexual Behavior.

Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II

D. D. Des Jarlais, G. Stimson, V. Poznyak, 2006, BMC public health.

Retention of patients who entered methadone maintenance via an interim methadone clinic.

D. D. Des Jarlais, R. Newman, S. E. Nichols, 1994, Journal of psychoactive drugs.

Criteria for judging methadone maintenance programs.

D. D. Des Jarlais, R. Newman, 1991, JAMA.

AIDS prevention among IV drug users: potential conflicts between research design and ethics.

D. D. Des Jarlais, S. Friedman, 1987, IRB.

Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.

D. D. Des Jarlais, J. Molès, K. Arasteh, 2016, The International journal on drug policy.

Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.

D. D. Des Jarlais, R. Byers, F. van Griensven, 2002, Journal of acquired immune deficiency syndromes.

Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.

D. D. Des Jarlais, A. Neaigus, E. Monterroso, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Unstable Housing as a Factor for Increased Injection Risk Behavior at US Syringe Exchange Programs

D. D. Des Jarlais, Naomi Braine, P. Friedmann, 2007, AIDS and Behavior.

Technical Papers on Health and Behavior Measurement

D. D. Des Jarlais, Naomi Braine, C. Turner, 1994 .

Incidence of HIV infection in a New York City methadone maintenance treatment program.

D. D. Des Jarlais, D. R. Prevots, D. Glebatis, 1996, JAMA.

Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry.

D. D. Des Jarlais, S. Magura, S. Deren, 2002, Drug and alcohol dependence.

Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment.

D. D. Des Jarlais, P. Flom, S. Deren, 2001, Journal of substance abuse treatment.

Association between injection practices and duration of injection among recently initiated injection drug users.

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2004, Drug and alcohol dependence.

HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

D. D. Des Jarlais, L. Torian, H. Hagan, 2010, Drug and alcohol dependence.

Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.

S. Galea, D. Vlahov, D. D. Des Jarlais, 2004, Ethnicity & disease.

Harm reduction in the USA: the research perspective and an archive to David Purchase

D. D. Des Jarlais, 2017, Harm Reduction Journal.

Doing harm reduction better: syringe exchange in the United States.

D. D. Des Jarlais, D. Purchase, C. McKnight, 2009, Addiction.

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

D. D. Des Jarlais, Z. Ross, K. Arasteh, 2018, PloS one.

The use of electronic debit cards in longitudinal data collection with geographically mobile drug users.

D. D. Des Jarlais, T. Perlis, J. Settembrino, 2005, Drug and alcohol dependence.

Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs

D. D. Des Jarlais, H. Tran, J. Molès, 2022, Biomedicines.

Introduction of human immunodeficiency virus infection among parenteral drug abusers in Sardinia: a seroepidemiologic study.

D. D. Des Jarlais, P. Farci, A. Balestrieri, 1988, American journal of epidemiology.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Madhu Sudhan Atteraya, Mohammad Hosein Farzaei, Fares Alahdab, 2018, The Lancet.

Perceived health and alcohol use in individuals with HIV and Hepatitis C who use drugs.

D. D. Des Jarlais, D. Hasin, J. Elliott, 2017, Addictive behaviors.

Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

D. D. Des Jarlais, H. Hagan, R. Braithwaite, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C virus‐specific immune responses in noninjecting drug users

D. D. Des Jarlais, K. Arasteh, A. Talal, 2012, Journal of viral hepatitis.

Drug Treatment Programs as Sites of Opportunity for the Delivery of Hepatitis C Prevention Education: Client and Staff Perspectives

D. D. Des Jarlais, H. Hagan, S. Strauss, 2004 .

Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

D. D. Des Jarlais, S. Tross, M. Raag, 2018, Drug and alcohol dependence.

Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel

T. Menza, D. D. Des Jarlais, S. Buskin, 2022, AIDS and Behavior.

Methadone maintenance patients in general medical practice. A preliminary report.

D. D. Des Jarlais, E. Pascarelli, H. Joseph, 1988, JAMA.

Symbiotic Goals and the Prevention of Blood-Borne Viruses Among Injection Drug Users

D. D. Des Jarlais, S. Friedman, P. Mateu-Gelabert, 2011, Substance use & misuse.

HIV surveillance among injecting drug users.

D. D. Des Jarlais, J. Casabona, K. Dehne, 2001, AIDS.

Understanding the long-term course of HIV epidemics.

D. D. Des Jarlais, 1998, AIDS.

Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions

D. D. Des Jarlais, D. Heckathorn, J. Molès, 2016, AIDS care.

Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

Eyal Oren, Kavitha Ranganathan, Nobhojit Roy, 2016, Lancet.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Ronan A Lyons, Fares Alahdab, Martin McKee, 2018, The Lancet.

Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs

D. D. Des Jarlais, H. Hagan, E. Pouget, 2011 .

Non-injection drug use and Hepatitis C Virus: a systematic review.

D. D. Des Jarlais, H. Hagan, P. Flom, 2007, Drug and alcohol dependence.

Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.

D. D. Des Jarlais, Maureen Miller, S. Friedman, 2002, Journal of acquired immune deficiency syndromes.

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.

D. Vlahov, R. Garfein, D. D. Des Jarlais, 2003, American journal of epidemiology.

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.

D. D. Des Jarlais, H. Hagan, S. Friedman, 2009, Drug and alcohol dependence.

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015

Reed J. D. Sorensen, Alan D. Lopez, Timothy M Wolock, 2016, The lancet. HIV.

Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis

D. D. Des Jarlais, H. Hagan, R. Braithwaite, 2014, Systematic Reviews.

A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.

D. D. Des Jarlais, H. Hagan, R. Scheinmann, 2009, Social science & medicine.

Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling.

R. Garfein, D. D. Des Jarlais, D. Heckathorn, 2009, The International journal on drug policy.

The HCV Synthesis Project: Scope, methodology, and preliminary results

D. D. Des Jarlais, H. Hagan, P. Flom, 2008, BMC medical research methodology.

Behavior Change and Health-Related Interventions for Heterosexual Risk Reduction Among Drug Users

D. D. Des Jarlais, R. Malow, S. Semaan, 2006, Substance use & misuse.

HIV Prevention Research: Cumulative Knowledge or Accumulating Studies?: An Introduction to the HIV/AIDS Prevention Research Synthesis Project Supplement

D. D. Des Jarlais, S. Semaan, 2002, Journal of acquired immune deficiency syndromes.

A Meta‐analysis of the Effect of HIV Prevention Interventions on the Sex Behaviors of Drug Users in the United States

L. Hedges, D. D. Des Jarlais, E. Sogolow, 2002, Journal of acquired immune deficiency syndromes.

HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

D. D. Des Jarlais, L. Torian, S. Friedman, 2000, American journal of public health.

Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.

D. D. Des Jarlais, F. Bastos, S. Friedman, 1994, Addiction.

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.

D. D. Des Jarlais, S. Tross, A. Uusküla, 2018, Drug and alcohol dependence.

Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future

D. D. Des Jarlais, A. Uusküla, R. Bluthenthal, 2018, Journal of Urban Health.

Can intranasal drug use reduce HCV infection among injecting drug users?

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2011, Drug and alcohol dependence.

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

M. Kals, D. D. Des Jarlais, T. Rhodes, 2008, Journal of public health.

The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.

D. D. Des Jarlais, D. Heckathorn, H. Hagan, 2007, Addiction.

AIDS and the transition to illicit drug injection--results of a randomized trial prevention program.

D. D. Des Jarlais, A. Rosenblum, S. Friedman, 1992, British journal of addiction.

Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City

D. D. Des Jarlais, K. Arasteh, J. Feelemyer, 2020, Global public health.

Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users.

D. D. Des Jarlais, A. Lechi, L. Romanò, 2004, Drug and alcohol dependence.

Report on the European Community Workshop on Epidemiology of HIV Infections: Spread among intravenous drug abusers and the heterosexual population. Robert Koch-Institute, Berlin, 12-14 November 1986.

D. D. Des Jarlais, J. Brunet, M. Koch, 1987, AIDS.

Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

David E. Rogers, Philip W. Brickner, D. E. Rogers, 1989, Annals of internal medicine.

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

D. D. Des Jarlais, H. Hagan, E. Pouget, 2008, American journal of epidemiology.

Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.

D. D. Des Jarlais, H. Hagan, S. Strauss, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reducing HIV infection among new injecting drug users in the China–Vietnam Cross Border Project

D. D. Des Jarlais, T. Hammett, R. Kling, 2007, AIDS.

Sexual Risk Reduction in a Cohort of Injecting Drug Users in Bangkok, Thailand

D. D. Des Jarlais, J. Tappero, F. van Griensven, 2003, Journal of acquired immune deficiency syndromes.

HIV Risk Reduction in a Cohort of Injecting Drug Users in Bangkok, Thailand

D. D. Des Jarlais, J. Tappero, F. van Griensven, 2003, Journal of acquired immune deficiency syndromes.

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.

D. D. Des Jarlais, Zunyou Wu, T. Hammett, 2008, Addiction.

Transitions from Injection-Drug-Use-Concentrated to Self-Sustaining Heterosexual HIV Epidemics: Patterns in the International Data

D. D. Des Jarlais, H. Hagan, L. Degenhardt, 2012, PloS one.

Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2011, American journal of public health.

Temporal Trends in Spatial Access to Pharmacies that Sell Over-the-Counter Syringes in New York City Health Districts: Relationship to Local Racial/Ethnic Composition and Need

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2009, Journal of Urban Health.

Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.

Don C Des Jarlais, Courtney McKnight, Patricia Friedmann, 2002, Journal of the American Pharmaceutical Association.

Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, M. Yancovitz, 2001, American journal of public health.

HIV and HCV infection among injecting drug users.

D. D. Des Jarlais, H. Hagan, H. Hagan, 2000, The Mount Sinai journal of medicine, New York.

Hepatitis vaccination among drug users.

D. D. Des Jarlais, A. Lechi, G. Quaglio, 2006, Vaccine.

Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.

D. D. Des Jarlais, Maureen Miller, S. Friedman, 2007, Drug and alcohol dependence.

Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.

D. D. Des Jarlais, Maureen Miller, S. Friedman, 2007, The Journal of infectious diseases.

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine

D. D. Des Jarlais, B. Schackman, E. Williams, 2022, Journal of addiction medicine.

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.

D. D. Des Jarlais, K. Delucchi, J. K. Manuel, 2013, American journal of public health.

Organizational Issues in the Implementation of a Hospital-Based Syringe Exchange Program

D. D. Des Jarlais, J. Sorensen, D. Perlman, 2010, Substance use & misuse.

Impact of monetary incentives on adherence to referral for screening chest X-rays after syringe exchange-based tuberculin skin testing

D. D. Des Jarlais, V. Schoeb, N. Salomon, 2003, Journal of Urban Health.

Tuberculosis screening at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, M. Perkins, 1997, American journal of public health.

Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).

D. D. Des Jarlais, A. Katz, Dongmei Li, 2017, The International journal on drug policy.

Targeted HIV-prevention programs.

D. D. Des Jarlais, W. Winkelstein, N. Padian, 1994, The New England journal of medicine.

Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2012, Drug and alcohol dependence.

Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.

D. D. Des Jarlais, S. Friedman, G. Touzé, 2007, The International journal on drug policy.

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2009, Harm reduction journal.

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Mohammad Hosein Farzaei, Fares Alahdab, Marcel Ausloos, 2018, Lancet.

D. D. Des Jarlais, S. Deren, 1977, The American journal of drug and alcohol abuse.

Incarceration and Risk for HIV Infection Among Injection Drug Users in Bangkok

D. D. Des Jarlais, T. Mastro, W. Heyward, 2002, Journal of acquired immune deficiency syndromes.

Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users

D. D. Des Jarlais, S. Friedman, R. Curtis, 1993, AIDS.

Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users

D. D. Des Jarlais, M. Pavlicova, S. Braunstein, 2016, BMC Health Services Research.

Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research.

D. D. Des Jarlais, S. Friedman, B. Tempalski, 2016, The International journal on drug policy.

Transitions to Injecting Drug Use Among Noninjecting Heroin Users: Social Network Influence and Individual Susceptibility

Don C Des Jarlais, Alan Neaigus, Maureen Miller, 2006, Journal of acquired immune deficiency syndromes.

What is AIDS doing to the drug research agenda?

D. D. Des Jarlais, J. Strang, G. Stimson, 1992, British journal of addiction.

Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review

A. Abdul-Quader, D. D. Des Jarlais, S. Semaan, 2013, AIDS and Behavior.

Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.

D. D. Des Jarlais, J. Esparza, T. Mastro, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Maintaining low HIV seroprevalence in populations of injecting drug users.

D. D. Des Jarlais, H. Hagan, M. Frischer, 1995, JAMA.

AIDS Health Education for Intravenous Drug Users

D. D. Des Jarlais, S. Friedman, J. L. Sotheran, 1986, Health education quarterly.

Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users.

Stephen Pilling, Don C Des Jarlais, N. Meader, 2010, The Cochrane database of systematic reviews.

Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.

D. D. Des Jarlais, S. Friedman, C. Maslow, 2002, American journal of public health.

Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

D. D. Des Jarlais, S. Friedman, D. C. Jarlais, 1998, Public health reports.

Using Retrospective Behavioral Data to Determine HIV Risk Factors among Street-Recruited Drug Injectors

D. D. Des Jarlais, S. Friedman, A. Rosenblum, 1995 .

Effects of outreach intervention on risk reduction among intravenous drug users.

D. D. Des Jarlais, A. Neaigus, S. Friedman, 1990, AIDS education and prevention : official publication of the International Society for AIDS Education.

Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.

Don C Des Jarlais, Richard Curtis, Alan Neaigus, 2002, Journal of acquired immune deficiency syndromes.

Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (hiv) epidemic in new york city

D. Vlahov, D. D. Des Jarlais, S. Friedman, 1989, Journal of medical virology.

Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.

D. D. Des Jarlais, J. Molès, K. Arasteh, 2020, AIDS.

HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

D. D. Des Jarlais, D. McCarty, W. Vega, 2013, The American psychologist.

Stigmatized Drug Use, Sexual Partner Concurrency, and Other Sex Risk Network and Behavior Characteristics of 18- to 24-Year-Old Youth in a High-Risk Neighborhood

D. D. Des Jarlais, J. Zenilman, S. Friedman, 2001, Sexually transmitted diseases.

Correlates of attempted suicide among young injection drug users in a multi-site cohort.

R. Garfein, J. Havens, D. D. Des Jarlais, 2004, Drug and alcohol dependence.

Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2013, Drug and alcohol dependence.

Neonatal, infant, and under-5 mortality and morbidity burden in the Eastern Mediterranean region: findings from the Global Burden of Disease 2015 study

Seyed M. Karimi, R. Malekzadeh, J. Frostad, 2017, International Journal of Public Health.

Prevalence and genotypes of GBV‐C and its associations with HIV infection among persons who inject drugs in Eastern Europe

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2017, Journal of medical virology.

Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.

Don C Des Jarlais, Holly Hagan, David M Rindskopf, 2006, Drug and alcohol dependence.

Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study

David M. Pereira, Seyed M. Karimi, T. Vos, 2017, International Journal of Public Health.

Drug use data, drug use theories and drug use policies in the United States: a combinatorial lack of connections.

D. D. Des Jarlais, 2015, Addiction.

Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers.

J. Tobin, D. D. Des Jarlais, P. Perumalswami, 2021, Journal of substance abuse treatment.

Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.

Sandra E. Larios, D. D. Des Jarlais, J. Sorensen, 2014, Journal of substance abuse treatment.

The relationship between health policy and public health interventions: a case study of the DRIVE project to “end” the HIV epidemic among people who inject drugs in Haiphong, Vietnam

D. D. Des Jarlais, N. Nagot, T. Hammett, 2018, Journal of public health policy.

The relationship between health policy and public health interventions: a case study of the DRIVE project to “end” the HIV epidemic among people who inject drugs in Haiphong, Vietnam

D. D. Des Jarlais, N. Nagot, T. Hammett, 2018, Journal of Public Health Policy.

Assessment of a psychiatric intervention at community level for people who inject drugs in a low-middle income country: the DRIVE-Mind cohort study in Hai Phong, Viet Nam

D. D. Des Jarlais, J. Molès, N. Nagot, 2021, The Lancet regional health. Western Pacific.

Development and assessment of a community-based screening tool for mental health disorders among people who inject drugs.

D. D. Des Jarlais, J. Molès, N. Nagot, 2021, Drug and alcohol review.

Daily heroin injection and psychiatric disorders: A cross-sectional survey among People Who Inject Drugs (PWID) in Haiphong, Vietnam.

D. D. Des Jarlais, J. Molès, N. Nagot, 2020, Drug and alcohol dependence.

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020

D. D. Des Jarlais, B. Schackman, D. Perlman, 2022, Drug and Alcohol Dependence.

The Impact of COVID-19 on Syringe Services Programs in the United States

D. D. Des Jarlais, S. Glick, Maria A. Corcorran, 2020, AIDS and Behavior.

Expansion of Syringe Service Programs in the United States, 2015-2018.

D. D. Des Jarlais, K. Arasteh, J. Feelemyer, 2020, American journal of public health.

Syringe Exchange in the United States: A National Level Economic Evaluation of Hypothetical Increases in Investment

David R. Holtgrave, D. D. Des Jarlais, S. Pinkerton, 2014, AIDS and Behavior.

Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2018, Journal of medical virology.

Modulators of “Activated Motivation”: Event-Specific Condom Use by Drug Injectors Who Have Used Condoms to Prevent HIV/AIDS

D. D. Des Jarlais, S. Friedman, M. Marmor, 1999, AIDS and Behavior.

Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients

D. D. Des Jarlais, C. Pattaro, A. Lechi, 2006, BMC public health.

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

D. D. Des Jarlais, H. Hagan, I. Jacobson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Provision of On-Site Medical Care to Patients With Hepatitis C in Drug Treatment Units

P. Friedmann, D. D. Des Jarlais, Z. Vassilev, 2004, Journal of health care for the poor and underserved.

HIV prevention for injecting drug users: the first 25 years and counting.

D. D. Des Jarlais, S. Semaan, 2008, Psychosomatic medicine.

HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities

D. D. Des Jarlais, E. Wood, K. Arasteh, 2009, Current opinion in HIV and AIDS.

Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors

R. Ahas, Siiri Silm, D. D. Des Jarlais, 2010, Sexually Transmitted Infections.

HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review

D. D. Des Jarlais, A. Uusküla, J. Feelemyer, 2023, European journal of public health.

Crack use and multiple AIDS risk behaviors.

A. Abdul-Quader, D. D. Des Jarlais, S. Tross, 1991, Journal of acquired immune deficiency syndromes.

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West

D. D. Des Jarlais, M. Rosińska, M. Raag, 2014, AIDS.

The differential effects of face-to-face and computer interview modes.

Phillip Cooley, Don C Des Jarlais, Denise Paone, 2002, American journal of public health.

Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

D. D. Des Jarlais, M. Busch, B. Rehermann, 2011, Journal of hepatology.

Sexual contexts and the process of risk reduction

D. D. Des Jarlais, Naomi Braine, Laurens G. Van Sluytman, 2011, Culture, health & sexuality.

Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Risk Environments, Race/Ethnicity, and HIV Status in a Large Sample of People Who Inject Drugs in the United States

D. D. Des Jarlais, S. Friedman, Z. Ross, 2016, PloS one.

Update on respondent-driven sampling: Theory and practical considerations for studies of persons who inject drugs

Yann Le Strat, Lucie Léon, Don Des Jarlais, 2016 .

Metropolitan Social Environments and Pre-HAART/HAART Era Changes in Mortality Rates (per 10,000 Adult Residents) among Injection Drug Users Living with AIDS

S. Galea, D. D. Des Jarlais, Jennifer Cantrell, 2013, PloS one.

Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.

Christopher M. Jones, D. D. Des Jarlais, S. Handanagic, 2021, American journal of preventive medicine.

What happened to the HIV epidemic among non‐injecting drug users in New York City?

D. D. Des Jarlais, H. Hagan, S. Tross, 2017, Addiction.

HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.

D. D. Des Jarlais, P. Carrieri, 2016, AIDS.

HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

D. D. Des Jarlais, A. Hatzakis, V. Arendt, 2020, The lancet. HIV.

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study

Alex S. Bennett, D. D. Des Jarlais, I. D. Aronson, 2020, JMIR formative research.

Prevention of HIV Infection in Street‐Recruited Injection Drug Users

D. Vlahov, D. D. Des Jarlais, S. Holmberg, 2000, Journal of acquired immune deficiency syndromes.

Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

D. D. Des Jarlais, S. Friedman, B. Tempalski, 2014, Annals of epidemiology.

Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

D. D. Des Jarlais, S. Friedman, B. Tempalski, 2008, The International journal on drug policy.

Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2011, American journal of public health.

Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting

D. D. Des Jarlais, S. Tross, M. Raag, 2019, AIDS and Behavior.

Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2018, Journal of acquired immune deficiency syndromes.

Hospital- versus community-based syringe exchange: a randomized controlled trial.

S. Hall, D. D. Des Jarlais, K. Delucchi, 2007, AIDS education and prevention : official publication of the International Society for AIDS Education.

HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Don C Des Jarlais, Samuel R Friedman, D. D. Des Jarlais, 2005, American journal of public health.

Respondent-Driven Sampling in a Study of Drug Users in New York City: Notes from the Field

Courtney McKnight, Don Des Jarlais, A. Abdul-Quader, 2006, Journal of Urban Health.

Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment

R. Remien, D. D. Des Jarlais, M. Pavlicova, 2021, AIDS and Behavior.

HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, PloS one.

HIV Vaccine Trials

D. D. Des Jarlais, M. Marmor, S. Vanichseni, 1998, Science.

Adapted “Break the Cycle for Avant Garde” intervention to reduce injection assisting and promoting behaviours in people who inject drugs in Tallinn, Estonia: A pre- post trial

D. D. Des Jarlais, S. Tross, M. Raag, 2022, medRxiv.

A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections

D. D. Des Jarlais, S. Tross, M. Raag, 2021, Frontiers in Sociology.

Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

Don C Des Jarlais, Anastasios Panopoulos, Lucas Wiessing, 2015, Addiction.

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, AIDS and Behavior.

Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.

D. D. Des Jarlais, C. McKnight, D. C. Jarlais, 2018, The International journal on drug policy.

Correlates of HIV Status Among Injection Drug Users in a Border Region of Southern China and Northern Vietnam

D. D. Des Jarlais, T. Hammett, R. Kling, 2005, Journal of acquired immune deficiency syndromes.

Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas.

D. D. Des Jarlais, S. Friedman, P. Flom, 2007, American journal of public health.

Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.

D. D. Des Jarlais, S. Friedman, Z. Ross, 2016, Annals of epidemiology.

Spatial Access to Sterile Syringes and the Odds of Injecting with an Unsterile Syringe among Injectors: A Longitudinal Multilevel Study

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2012, Journal of Urban Health.

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2012, Health & place.

Trends in the AIDS epidemic among New York City’s injection drug users: Localized or citywide?

D. D. Des Jarlais, S. Friedman, S. Deren, 2002, Journal of Urban Health.

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.

M Beardsley, D. D. Des Jarlais, L. Torian, 1998, American journal of public health.

Provider Perspectives on Barriers to Routine HIV Testing of Adolescent and Young Adult Patients in Emergency Department Settings

Alex S. Bennett, D. D. Des Jarlais, L. Chernick, 2021, Behavioral medicine.

Alarming Tuberculosis Rate Among People Who Inject Drugs in Vietnam

D. D. Des Jarlais, J. Molès, N. Nagot, 2021, Open forum infectious diseases.

Condom availability in New York City public high schools: relationships to condom use and sexual behavior.

D. D. Des Jarlais, S. Guttmacher, N. Freudenberg, 1997, American journal of public health.

Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia

M. Kals, D. D. Des Jarlais, A. Uusküla, 2011, BMC public health.

Consistent condom use among drug-using youth in a high HIV-risk neighbourhood

D. D. Des Jarlais, J. Zenilman, S. Friedman, 2002, AIDS care.

Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users

D. D. Des Jarlais, H. Hagan, Z. Vassilev, 2006, International journal of STD & AIDS.

D. D. Des Jarlais, M. Frischer, S. Friedman, 1995, AIDS.

Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries

D. D. Des Jarlais, R. Pollini, C. Latkin, 2014, BMC Health Services Research.

Syringe Disposal Among Injection Drug Users in Harlem and the Bronx During the New York State Expanded Syringe Access Demonstration Program

D. Vlahov, D. D. Des Jarlais, S. Blaney, 2007, Health Education & Behavior.

Impact of a needle exchange program on potentially infectious syringes in public places.

D. D. Des Jarlais, S. Friedman, L. Magnuson, 1992, Journal of acquired immune deficiency syndromes.

Increased Methamphetamine Use among Persons Who Inject Drugs in Hai Phong, Vietnam, and the Association with Injection and Sexual Risk Behaviors

D. D. Des Jarlais, J. Molès, K. Arasteh, 2018, Journal of psychoactive drugs.

A randomized trial of an interim methadone maintenance clinic.

D. D. Des Jarlais, S. Yancovitz, P. Friedmann, 1991, American journal of public health.

HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users

D. D. Des Jarlais, D. Hasin, M. Stohl, 2016, AIDS and Behavior.

Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.

D. D. Des Jarlais, M. McGrath, S. Friedman, 2007, The International journal on drug policy.

Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China

D. D. Des Jarlais, T. Hammett, R. Kling, 2005, BMC public health.

HIV prevention for injection drug users in China and Vietnam: Policy and research considerations

D. D. Des Jarlais, T. Hammett, R. Kling, 2007, Global public health.

Reflections on 25 Years of HIV and AIDS Research among Drug Abusers

D. D. Des Jarlais, S. Friedman, R. Booth, 2009 .

Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

D. D. Des Jarlais, H. Hagan, S. Friedman, 2009, American journal of public health.

Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya

D. D. Des Jarlais, A. Kurth, P. Cherutich, 2015, Journal of acquired immune deficiency syndromes.

HIV Infection Among People Who Inject Drugs in the United States: Geographically Explained Variance Across Racial and Ethnic Groups.

T. Finlayson, D. D. Des Jarlais, Z. Ross, 2015, American journal of public health.

Perceived risk for severe outcomes and drinking status among drug users with HIV and Hepatitis C Virus (HCV).

D. D. Des Jarlais, D. Hasin, J. Elliott, 2016, Addictive behaviors.

Multiple routes of drug administration and HIV risk among injecting drug users.

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2012, Journal of substance abuse treatment.

Sexual Risk and HIV Infection Among Drug Users in New York City: A Pilot Study

D. D. Des Jarlais, H. Hagan, D. Perlman, 2011, Substance use & misuse.

Peer-Driven Interventions in Vietnam and China to Prevent HIV: A Pilot Study Targeting Injection Drug Users

W. Liu, D. D. Des Jarlais, R. Broadhead, 2009 .

Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas

D. D. Des Jarlais, S. Friedman, P. Flom, 2006, AIDS.

HIV and injecting drug use.

D. D. Des Jarlais, M. Carballo, 1993, AIDS & society.

"Single-use" needles and syringes for the prevention of HIV infection among injection drug users.

D. D. Des Jarlais, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Racialized risk environments in a large sample of people who inject drugs in the United States.

D. D. Des Jarlais, S. Friedman, Z. Ross, 2016, The International journal on drug policy.

Identifying Which Place Characteristics are Associated with the Odds of Recent HIV Testing in a Large Sample of People Who Inject Drugs in 19 US Metropolitan Areas

D. D. Des Jarlais, S. Friedman, Z. Ross, 2018, AIDS and Behavior.

Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C)

D. D. Des Jarlais, P. Vickerman, J. Molès, 2020, BMJ Open.

Diffusion of the D.A.R.E and syringe exchange programs.

D. D. Des Jarlais, Z. Sloboda, S. Friedman, 2006, American journal of public health.

Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).

D. D. Des Jarlais, J. Richardson, K. Weber, 2004, AIDS patient care and STDs.

Stigmatization of newly emerging infectious diseases: AIDS and SARS.

Sandro Galea, Don C Des Jarlais, Melissa Tracy, 2006, American journal of public health.

Thick trust, thin trust, social capital, and health outcomes among trans women of color in New York City.

D. D. Des Jarlais, S. Hwahng, C. McKnight, 2021, International journal of transgender health.

Doing a shotgun: a drug use practice and its relationship to sexual behaviors and infection risk.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1999, Social science & medicine.

Commentary on Grebely et al. (2019): Ending HCV epidemics among people who inject drugs.

D. D. Des Jarlais, 2018, Addiction.

Controlling HIV Epidemics among Injection Drug Users: Eight Years of Cross-Border HIV Prevention Interventions in Vietnam and China

W. Liu, D. D. Des Jarlais, J. Mcnicholl, 2012, PloS one.

Role of Sexual Transmission of HIV Among Young Noninjection and Injection Opiate Users: A Respondent-Driven Sampling Study

D. D. Des Jarlais, Hongjie Liu, Jian-hua Li, 2011, Sexually transmitted diseases.

Hazardous Drinking and HIV Sexual Risk Behaviors Among Injection Drug Users in Developing and Transitional Countries

D. D. Des Jarlais, K. Arasteh, On behalf of the Centers for Aids Research—Collaborat Group, 2010, AIDS and Behavior.

A Perfect Storm: Crack Cocaine, HSV-2, and HIV Among Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Substance use & misuse.

Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City.

Don C Des Jarlais, Richard Curtis, Alan Neaigus, 2003, Addiction.

Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers: a randomized controlled trial.

D. D. Des Jarlais, J. Connett, K. Resnicow, 2013, Addiction.

Working With Persons Who Inject Drugs and Live in Rural Areas: Implications From China/Vietnam for the USA

D. D. Des Jarlais, T. Hammett, J. Feelemyer, 2018, Current HIV/AIDS Reports.

Sexual Health in Art and Science

D. D. Des Jarlais, S. Semaan, S. Bice, 2006, Emerging infectious diseases.

How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation

D. D. Des Jarlais, N. Nagot, L. Michel, 2022, Harm Reduction Journal.

A qualitative study of persons who inject drugs but who have never helped others with first injections: how their views on helping contrast with the views of persons who have helped with first injections, and implications for interventions

D. D. Des Jarlais, S. Tross, D. M. Barnes, 2018, Harm Reduction Journal.

A Profile of U.S.‐Based Trials of Behavioral and Social Interventions for HIV Risk Reduction

D. D. Des Jarlais, E. Sogolow, P. Mullen, 2002, Journal of acquired immune deficiency syndromes.

Structural interventions to reduce HIV transmission among injecting drug users

D. D. Des Jarlais, 2000, AIDS.

Preventing opportunistic infections in HIV-infected injection drug users.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1997, JAMA.

Designing a smoking cessation intervention for the unique needs of homeless persons: a community-based randomized clinical trial

D. D. Des Jarlais, J. Connett, K. Resnicow, 2011, Clinical trials.

Social Support and Response to AIDS and Severe Acute Respiratory Syndrome

S. Galea, D. D. Des Jarlais, A. Nandi, 2008, Emerging infectious diseases.

Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam.

D. D. Des Jarlais, D. Heckathorn, J. Molès, 2018, Drug and alcohol dependence.

Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization

D. D. Des Jarlais, J. Sorensen, M. Shumway, 2017, Journal of ethnicity in substance abuse.

A decline in the prevalence of injecting drug users in Estonia, 2005-2009.

D. D. Des Jarlais, A. Uusküla, A. Talu, 2013, The International journal on drug policy.

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2015, The International journal on drug policy.

Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.

D. D. Des Jarlais, A. Lechi, G. Talamini, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Automated Substance Use/Sexual Risk Reporting and HIV Test Acceptance Among Emergency Department Patients Aged 13–24 Years

D. D. Des Jarlais, L. Marsch, L. Chernick, 2021, AIDS and Behavior.

The next problem: maintenance of AIDS risk reduction among intravenous drug users.

A. Abdul-Quader, D. D. Des Jarlais, S. Tross, 1991, The International journal of the addictions.

Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.

D. D. Des Jarlais, C. Pattaro, G. Quaglio, 2008, Drug and alcohol dependence.

Ethical considerations in surveys employing respondent-driven sampling.

R. Garfein, D. D. Des Jarlais, D. Heckathorn, 2010, American journal of public health.

Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2013, The International journal on drug policy.

Mathilde Krim, amfAR, and the prevention of HIV infection among injecting drug users: a brief history.

D. D. Des Jarlais, 2006, AIDS patient care and STDs.

Outreach to injecting drug users and female sexual partners of drug users on the lower east side of New York City.

A. Abdul-Quader, D. D. Des Jarlais, S. Tross, 1992, British journal of addiction.

Examining a Causal Model of Early Drug Involvement among Inner-City Junior High School Youths

D. Farrow, D. D. Des Jarlais, R. Dembo, 1981 .

Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2012, Addiction.

Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs

D. D. Des Jarlais, S. Friedman, R. Curtis, 1994, AIDS.

Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United. States

D. D. Des Jarlais, S. Friedman, S. Friedman, 1993, AIDS.

Social Factors Associated with AIDS and SARS

S. Galea, D. D. Des Jarlais, S. Tross, 2005, Emerging infectious diseases.

Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam

D. D. Des Jarlais, J. Molès, K. Arasteh, 2023, International journal of STD & AIDS.

Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014.

D. D. Des Jarlais, H. Hagan, S. Tross, 2016, American journal of public health.

Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City

A. Abdul-Quader, D. D. Des Jarlais, D. Heckathorn, 2007, AIDS.

Higher Viral Loads and Other Risk Factors Associated With HIV‐1 Seroconversion During a Period of High Incidence Among Injection Drug Users in Bangkok

D. D. Des Jarlais, R. Byers, F. van Griensven, 2002 .

Preventing HIV transmission among injecting drug users (IDUs) and from IDUs to noninjecting sexual partners in Sichuan, China.

D. D. Des Jarlais, 2007, Sexually Transmitted Diseases.

HIV Among Drug Users in China

D. D. Des Jarlais, C. Feng, 2002, Science.

Behavioral Correlates of COVID-19 Worry: Stigma, Knowledge, and News Source

D. D. Des Jarlais, V. Chang, Lawrence H. Yang, 2021, International journal of environmental research and public health.

Society, Drug Injectors, and AIDS

D. D. Des Jarlais, S. Friedman, B. Stepherson, 1992, Journal of health care for the poor and underserved.

Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.

D. D. Des Jarlais, A. Hatzakis, S. Friedman, 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Hepatitis C among drug users: déjà vu all over again?

A. Schuchat, D. D. Des Jarlais, 2001, American journal of public health.

Harm reduction--a framework for incorporating science into drug policy.

D. D. Des Jarlais, 1995, American journal of public health.

Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2008, Canadian Medical Association Journal.

Place-based predictors of HIV viral suppression and durable suppression among heterosexuals in New York city

D. D. Des Jarlais, S. Braunstein, H. Cooper, 2018, AIDS care.

HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand.

D. D. Des Jarlais, S. Friedman, M. Carballo, 1992, Journal of acquired immune deficiency syndromes.

Papanicolaou and Kruger assessment of sperm morphology: thresholds and agreement.

D. D. Des Jarlais, M. Vazquez-Levin, H. Nagler, 1998, International journal of andrology.

HIV Testing and Treatment Among At-Risk Drinking Injection Drug Users

D. D. Des Jarlais, K. Arasteh, 2009, Journal of the International Association of Physicians in AIDS Care.

Estimating number of diagnosed persons living with HIV in the United States engaged in unprotected serodiscordant risk behavior with unsuppressed viral load.

David R. Holtgrave, D. D. Des Jarlais, Y. Mizuno, 2014, Journal of acquired immune deficiency syndromes.

Medical maintenance feasibility study.

D. D. Des Jarlais, H. Joseph, V. Dole, 1985, NIDA research monograph.

Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.

R. Rosenthal, I. Galynker, D. D. Des Jarlais, 2000, The Mount Sinai journal of medicine, New York.

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.

P Mock, Lillian S. Lin, D. D. Des Jarlais, 1999, Journal of acquired immune deficiency syndromes.

HIV risk behaviors among Dominican brothel and street prostitutes in New York City.

D. D. Des Jarlais, S. Deren, M. Shedlin, 1996, AIDS education and prevention : official publication of the International Society for AIDS Education.

Use of the “NYC Condom” among People Who Use Drugs

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Journal of Urban Health.

"I Didn't Know What They're Gonna Do to Me: So That's Why I Said No": Why Youth Decline HIV Testing in Emergency Departments.

Alex S. Bennett, D. D. Des Jarlais, L. Chernick, 2022, Behavioral medicine.

HIV / STDs and drug use.

D. D. Des Jarlais, 1997, AIDS/STD health promotion exchange.

Gender and Age Patterns in HSV-2 and HIV Infection Among Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, S. Friedman, 2010, Sexually transmitted diseases.

Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection--MMT is not a single variable.

D. D. Des Jarlais, 2015, Addiction.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021

D. D. Des Jarlais, B. Schackman, D. Perlman, 2022, Public health reports.

Outpatient Drug Treatment Program Directors' Hepatitis C‐Related Beliefs and Their Relationship to the Provision of HCV Services

D. D. Des Jarlais, H. Hagan, S. Strauss, 2004, The American journal of drug and alcohol abuse.

State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness

D. D. Des Jarlais, K. Arasteh, J. Feelemyer, 2015, Journal of Public Health Policy.

Sociodemographic and behavioral factors associated with COVID-19 stigmatizing attitudes in the U.S.

D. D. Des Jarlais, Lawrence H. Yang, Gabriella Y. Meltzer, 2021, Stigma and Health.

Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.

D. D. Des Jarlais, S. Tross, K. Arasteh, 2019, Drug and alcohol dependence.

Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus

D. D. Des Jarlais, H. Hagan, S. Tross, 2017, Sexually transmitted diseases.

Transitions from injecting to non-injecting drug use: potential protection against HCV infection.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Journal of substance abuse treatment.

HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2013, PloS one.

Herpes Simplex Virus-2 and HIV Among Noninjecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, S. Friedman, 2007, Sexually transmitted diseases.

Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City.

D. D. Des Jarlais, W. El-Sadr, E. Wish, 1987, New York state journal of medicine.

Interventions for injecting drug users.

A. Abdul-Quader, D. D. Des Jarlais, S. Friedman, 2002 .

Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2016, Medical Microbiology and Immunology.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Eun Sug Park, Mohammad Sadegh Hassanvand, T. H. Nguyen, 2017, Lancet.

Treatment for drug dependence.

D. D. Des Jarlais, R. Hubbard, 1999, Proceedings of the Association of American Physicians.

Validity of self-reported data, scientific methods and drug policy.

D. D. Des Jarlais, 1998, Drug and Alcohol Dependence.

Mobile Augmented Screening to Increase HIV Testing Among Emergency Department Patients as Young as 13 Years

D. D. Des Jarlais, L. Marsch, L. Chernick, 2021, Cureus.

HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA

D. D. Des Jarlais, S. Glick, C. McKnight, 2023, Harm Reduction Journal.

A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam

T. T. Lien, Josephine G. Walker, D. D. Des Jarlais, 2023, The Lancet regional health. Western Pacific.

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2015, The International journal on drug policy.

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Nobhojit Roy, Anders Larsson, Ivy Shiue, 2014, The Lancet.

Correlates of Drug Treatment Program Staff's Self Efficacy to Support Their Clients' Hepatitis C Virus (HCV) Related Needs

D. D. Des Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2007, The American journal of drug and alcohol abuse.

Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.

Brian H. Bossak, D. D. Des Jarlais, S. Friedman, 2009, The International journal on drug policy.

Could cannabis liberalisation lead to wider changes in drug policies and outcomes?

D. D. Des Jarlais, P. Griffiths, B. Hughes, 2018, The International journal on drug policy.

COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources

D. D. Des Jarlais, J. Feelemyer, Gabriella Y. Meltzer, 2023, PLoS ONE.

Doing harm reduction better: syringe exchange in the United States.

D. D. Des Jarlais, D. Purchase, C. McKnight, 2009, Addiction.

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study

Alex S. Bennett, D. D. Jarlais, D. D. Des Jarlais, 2020, JMIR formative research.

National and international aspects of doing harm reduction better.

D. D. Des Jarlais, 2009, Addiction.

Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions

D. D. Des Jarlais, D. Heckathorn, J. Molès, 2016, AIDS care.

Socioeconomic and racial/ethnic spatial polarization and incarceration among people who inject drugs in 19 US metropolitan areas, 2015

Howard H. Chang, D. D. Des Jarlais, Justin C. Smith, 2023, SSM - population health.

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

D. D. Des Jarlais, H. Hagan, E. Pouget, 2011, The Journal of infectious diseases.

Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients

D. D. Des Jarlais, C. Pattaro, A. Lechi, 2006, BMC public health.

The first and second decades of AIDS among injecting drug users.

D. D. Des Jarlais, 1992, British journal of addiction.